The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ANAPTYSBIO INC | COM | 032724106 | 11,086,146 | 357,733 | SH | SOLE | 357,733 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 10,947,200 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 14,768,665 | 665,555 | SH | SOLE | 665,555 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 858,031 | 1,134,511 | SH | SOLE | 1,134,511 | 0 | 0 | ||
CINCOR PHARMA INC | COM | 17240Y109 | 60,683,669 | 4,937,646 | SH | SOLE | 4,937,646 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 9,137,486 | 790,440 | SH | SOLE | 790,440 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 15,779,834 | 862,286 | SH | SOLE | 862,286 | 0 | 0 | ||
DISC MEDICINE INC | COM | 254604101 | 11,704,111 | 588,442 | SH | SOLE | 588,442 | 0 | 0 | ||
ENTRADA THERAPEUTICS INC | COM | 29384C108 | 59,601,284 | 4,408,379 | SH | SOLE | 4,408,379 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 3,613,840 | 225,583 | SH | SOLE | 225,583 | 0 | 0 | ||
HOMOLOGY MEDICINES INC | COM | 438083107 | 5,715,258 | 4,535,919 | SH | SOLE | 4,535,919 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 21,736,735 | 1,196,298 | SH | SOLE | 1,196,298 | 0 | 0 | ||
IMPEL NEUROPHARMA INC | COM | 45258K109 | 10,817,966 | 2,884,791 | SH | SOLE | 2,884,791 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 8,234,843 | 384,626 | SH | SOLE | 384,626 | 0 | 0 | ||
JANUX THERAPEUTICS INC | COM | 47103J105 | 5,877,323 | 446,266 | SH | SOLE | 446,266 | 0 | 0 | ||
PEAR THERAPEUTICS INC | CLASS A COM | 704723105 | 19,758,053 | 16,744,113 | SH | SOLE | 16,744,113 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 6,610,500 | 587,600 | SH | SOLE | 587,600 | 0 | 0 | ||
RALLYBIO CORP | COM | 75120L100 | 24,510,857 | 3,730,724 | SH | SOLE | 3,730,724 | 0 | 0 | ||
SCPHARMACEUTICALS INC | COM | 810648105 | 19,608,889 | 2,734,852 | SH | SOLE | 2,734,852 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 8,763,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
VOR BIOPHARMA INC | COM | 929033108 | 42,305,458 | 6,361,723 | SH | SOLE | 6,361,723 | 0 | 0 |